Search Within

Ayca Gucalp

Formats
  1. Meeting Abstract (72)
  2. Journal Article (37)
  3. Book Section (3)
  4. Review (1)
Groups
  1. Breast Medicine Service (113)
  2. Department of Medicine (113)
  3. Solid Tumor Oncology Division (113)
  4. Survivorship Research (92)
  5. Population Sciences Research Program (49)
  6. Epidemiology and Biostatistics (46)

More Groups

People
  1. Tiffany Traina (59)
  2. Clifford Hudis (48)
  3. Neil Iyengar (29)
  4. Sujata Patil (24)
  5. Dilip Giri (20)
  6. Monica Morrow (15)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (1)
  4. 2022 (6)
  5. 2021 (3)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Cancer Research (23)
  3. Annals of Oncology (7)
  4. Breast Cancer Research and Treatment (5)
  5. Clinical Cancer Research (4)
  6. International Journal of Radiation Oncology, Biology, Physics (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (35)
  2. American Association for Cancer Research (29)
  3. Springer (11)
  4. Oxford University Press (9)
  5. Elsevier Inc. (8)
  6. Wiley Blackwell (3)

More Publishers

Results (113)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 open-label study evaluating the safety, tolerability, and pharmacokinetics of enzalutamide alone or combined with an aromatase inhibitor in women with advanced breast cancer
    Meeting Abstract

    Traina, T. A.; Yardley, D. A.; Patel, M. R.; Schwartzberg, L. S.; Elias, A.; Gucalp, A.; Blaney, M. E.; Gibbons, J.; Hudis, C. A.; LoRusso, P.
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Beyond Jeopardy!: Harnessing IBM's Watson to improve oncology decision making
    Meeting Abstract

    Bach, P.; Zauderer, M. G.; Gucalp, A.; Epstein, A. S.; Norton, L.; Seidman, A. D.; Caroline, A.; Grigorenko, A.; Bartashnik, A.; Wagner, I.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase 1 open-label, dose-escalation study evaluating the safety, tolerability, and pharmacokinetics of enzalutamide (previously MDV3100) alone or in combination with an aromatase inhibitor in women with advanced breast cancer
    Meeting Abstract

    Traina, T. A.; Yardley, D. A.; Patel, M.; Schwartzberg, L.; Elias, A.; Gucalp, A.; Peterson, A. C.; Hannah, A.; Gibbons, J.; Khondker, Z.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A phase 2 single-arm study of the clinical activity and safety of enzalutamide in patients with advanced androgen receptor-positive triple-negative breast cancer
    Meeting Abstract

    Traina, T. A.; O'Shaughnessy, J.; Kelly, C.; Schwartzberg, L.; Gucalp, A.; Peterson, A.; Bhattacharya, S.; Trudeau, M.; Hudis, C. A.; Schmid, P.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A multicenter phase II study of docosahexaenoic acid (DHA) in triple negative breast cancer (TNBC) survivors
    Meeting Abstract

    Gucalp, A.; Morris, P. G.; Zhou, X. K.; Giri, D. D.; Iyengar, N. M.; Heckman-Stoddard, B. M.; Dunn, B.; Garber, J. E.; Crew, K. D.; Hershman, D. L.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Validating the link between obesity and breast inflammation in women with breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Morris, P. G.; Zhou, X. K.; Giri, D. D.; Harbus, M. D.; Falcone, D. J.; Gucalp, A.; Morrow, M.; Hudis, C. A.; Dannenberg, A. J.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Understanding triple-negative breast cancer
    Book Section

    Gucalp, A.; Traina, T. A.
    In Ahmad, A. (Eds.) Breast Cancer Metastasis and Drug Resistance: Progress and Prospects (2013)

    Fulltext@MSK | Save
  • Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer
    Journal Article

    Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K.; Rugo, H.; Nabell, L.; Forero, A.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Omega-3 fatty acids for prevention of breast cancer: An update and the state of the science
    Journal Article

    Iyengar, N. M.; Hudis, C. A.; Gucalp, A.
    Current Breast Cancer Reports (2013)

    Fulltext@MSK | Save
  • The role of the androgen receptor in triple-negative breast cancer
    Journal Article

    Shah, P. D.; Gucalp, A.; Traina, T. A.
    Women's Health (2013)

    Fulltext@MSK | Save